Solventum (SOLV) Competitors $65.97 -1.83 (-2.69%) Closing price 04/15/2025 03:59 PM EasternExtended Trading$65.26 -0.71 (-1.08%) As of 05:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, NARI, INSP, and BLCOShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), and Bausch + Lomb (BLCO). These companies are all part of the "medical equipment" industry. Solventum vs. GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew Penumbra Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Solventum (NYSE:SOLV) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, community ranking, valuation, earnings and risk. Do analysts prefer SOLV or GEHC? Solventum presently has a consensus price target of $79.86, indicating a potential upside of 21.04%. GE HealthCare Technologies has a consensus price target of $97.73, indicating a potential upside of 54.88%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00GE HealthCare Technologies 1 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.75 Is SOLV or GEHC more profitable? GE HealthCare Technologies has a net margin of 10.13% compared to Solventum's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A GE HealthCare Technologies 10.13%25.74%6.29% Does the media refer more to SOLV or GEHC? In the previous week, GE HealthCare Technologies had 14 more articles in the media than Solventum. MarketBeat recorded 28 mentions for GE HealthCare Technologies and 14 mentions for Solventum. Solventum's average media sentiment score of 1.39 beat GE HealthCare Technologies' score of 1.23 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 14 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 18 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer SOLV or GEHC? GE HealthCare Technologies received 25 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 61.90% of users gave GE HealthCare Technologies an outperform vote while only 4.17% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes14.17%Underperform Votes2395.83% GE HealthCare TechnologiesOutperform Votes2661.90% Underperform Votes1638.10% Do institutionals & insiders believe in SOLV or GEHC? 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.1% of Solventum shares are owned by insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has better earnings & valuation, SOLV or GEHC? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.25B1.38$475.76M$2.7523.99GE HealthCare Technologies$19.67B1.47$1.99B$4.3314.57 SummaryGE HealthCare Technologies beats Solventum on 16 of the 18 factors compared between the two stocks. Remove Ads Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$11.41B$4.07B$5.33B$18.52BDividend YieldN/A39.49%5.11%4.22%P/E Ratio23.9927.6321.6631.15Price / Sales1.3850.21377.4825.69Price / CashN/A51.0838.1517.53Price / BookN/A5.826.454.29Net Income$475.76M$67.09M$3.20B$1.02B7 Day Performance-3.84%-0.17%2.83%-0.79%1 Month Performance-11.22%-3.20%-8.58%-6.88%1 Year Performance6.46%14.84%10.35%1.74% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum1.7044 of 5 stars$65.97-2.7%$79.86+21.0%+6.9%$11.41B$8.25B23.9922,000Positive NewsGEHCGE HealthCare Technologies4.303 of 5 stars$64.50+2.7%$97.73+51.5%-26.7%$29.50B$19.67B14.9050,000Short Interest ↓Positive NewsPHGKoninklijke Philips3.2113 of 5 stars$23.83+1.8%N/A+16.8%$22.40B$18.02B-28.3778,200Positive NewsZBHZimmer Biomet4.6972 of 5 stars$102.11-0.2%$124.15+21.6%-21.6%$20.33B$7.68B22.9518,000Analyst ForecastNews CoveragePositive NewsSNNSmith & Nephew2.6486 of 5 stars$26.06+0.8%$27.00+3.6%+9.2%$11.39B$5.81B12.0620,100News CoveragePositive NewsGap DownPENPenumbra3.8652 of 5 stars$270.64-0.6%$293.80+8.6%+29.5%$10.47B$1.19B796.003,900Upcoming EarningsAnalyst ForecastShort Interest ↑Gap DownSTVNStevanato Group1.7355 of 5 stars€22.21+1.4%N/A-23.5%$6.73B$1.10B47.264,650Positive NewsGap DownGKOSGlaukos4.5648 of 5 stars$92.85+3.1%$159.50+71.8%-2.4%$5.25B$383.48M-32.35780Analyst ForecastNARIInari Medical0.3477 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.6411 of 5 stars$149.22+1.1%$226.70+51.9%-34.3%$4.44B$802.80M86.251,246Analyst ForecastNews CoveragePositive NewsGap UpBLCOBausch + Lomb3.8813 of 5 stars$12.26+7.5%$18.82+53.5%-16.5%$4.33B$4.79B-13.4712,500Gap Up Remove Ads Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives GKOS Alternatives NARI Alternatives INSP Alternatives BLCO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
